Abstract:Simple Summary Magnetic resonance imaging (MRI) has been considered a noninvasive prognostic biomarker in some cancers; however, the correlation with pancreatic ductal adenocarcinoma (PDAC) remains inconclusive. The aim of our study was to identify quantitative MRI parameters associated with prognosis and recurrence patterns. In an analysis of data from the 136 patients ultimately included in this study, we found that the value of the pure diffusion coefficient D in intravoxel incoherent MRI is an independent risk factor for overall survival (OS) and recurrence-free survival (RFS), while a low value of D is significantly associated with a higher risk of local recurrence. All the patients have been operated on with histopathology for further evaluation. Based on the results of our research, we believe that it is possible in clinical practice to stratify patients based on quantitative MRI data in order to guide treatment strategies, reduce the risk of local tumor recurrence, and improve patients' prognosis. Magnetic resonance imaging (MRI) has been shown to be associated with prognosis in some tumors; however, the correlation in pancreatic ductal adenocarcinoma (PDAC) remains inconclusive. In this retrospective study, we ultimately included 136 patients and analyzed quantitative MRI parameters that are associated with prognosis and recurrence patterns in PDAC using survival analysis and competing risks models; all the patients have been operated on with histopathology and immunohistochemical staining for further evaluation. In intravoxel incoherent motion diffusion-weighted imaging (DWI), we found that pure-diffusion coefficient D value was an independent risk factor for overall survival (OS) (HR: 1.696, 95% CI: 1.003-2.869, p = 0.049) and recurrence-free survival (RFS) (HR: 2.066, 95% CI: 1.252-3.409, p = 0.005). A low D value (<= 1.08 x 10(-3) mm(2)/s) was significantly associated with a higher risk of local recurrence (SHR: 5.905, 95% CI: 2.107-16.458, p = 0.001). Subgroup analysis revealed that patients with high D and f values had significantly better outcomes with adjuvant chemotherapy. Distant recurrence patients in the high-D value group who received chemotherapy may significantly improve their OS and RFS. It was found that preoperative multiparametric quantitative MRI correlates with prognosis and recurrence patterns in PDAC. Diffusion coefficient D value can be used as a noninvasive biomarker for predicting prognosis and recurrence patterns in PDAC.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Pancreatic Ductal Adenocarcinoma at 3.0-T Magnetic Resonance: Correlation with Histopathology.

Assessment of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Differentiation of Pancreatic Ductal Adenocarcinoma from Other Pancreatic Solid Lesions.

Comparison of Double Contrast-Enhanced Ultrasound and MDCT for Assessing Vascular Involvement of Pancreatic Adenocarcinoma: Preliminary Results Correlated with Surgical Findings

Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation

The Correlation Between Diffusion-Weighted Imaging at 3.0-T Magnetic Resonance Imaging and Histopathology for Pancreatic Ductal Adenocarcinoma

Dynamic Contrast-Enhanced Mri of Gastric Cancer: Correlations of the Pharmacokinetic Parameters with Histological Type, Lauren Classification, and Angiogenesis

Research on dynamic contrast-enhanced MR quantitative analysis of pancreatic cancer at 3.0T MR

Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters.

Differentiation of Pancreatic Neuroendocrine Carcinoma from Pancreatic Ductal Adenocarcinoma Using Magnetic Resonance Imaging: the Value of Contrast-Enhanced and Diffusion Weighted Imaging

Comparative Diagnostic Evaluation with Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Patients with Pancreatic Cystic Neoplasms

Differentiation of Pancreatic Ductal Adenocarcinoma from Inflammatory Mass: Added Value of Magnetic Resonance Elastography.

Dynamic Contrast-Enhanced Computed Tomography Functional Imaging for the Evaluation of Tumor Angiogenesis in Patients with Lung Carcinoma

Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma

Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.

Prostate Cancer: Diagnostic Value of Quantitative Analysis by Dynamic Contrast-Enhanced MR at 3.0 T

Correlation between dynamic contrast-enhanced MRI and diffusion-weighted imaging of prostate cancer

Evaluation of Pancreatic Cancer by Multiple Breath-Hold Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 3.0T.

Differentiation of Pancreatic Carcinoma and Mass-Forming Focal Pancreatitis: Qualitative and Quantitative Assessment by Dynamic Contrast-Enhanced MRI Combined with Diffusion-Weighted Imaging

Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density

Characteristics of 3.0T Dynamic Contrast-enhanced Magnetic Resonance Imaging of Lung Cancer and Its Correlation with Microvessel Density

Three-dimensional Contrast Enhanced Ultrasound Score and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Score in Evaluating Breast Tumor Angiogenesis: Correlation with Biological Factors.